Biggest changeExecutive Summary Comparing fiscal 2023 and fiscal 2022, our results included the following: • an increase in net sales from $6.04 billion to $6.26 billion, representing period-over-period growth of 3.6%; • comparable sales growth of 1.8%; • net loss attributable to Class A and B-1 common stockholders of $1,280.2 million impacted by goodwill impairment, compared to net income attributable to Class A and B-1 common stockholders of $90.8 million in the prior year; and • A decrease in Adjusted EBITDA from $530.8 million to $401.1 million. 51 Results of Operations The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands): Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (53 weeks) (52 weeks) (52 weeks) Net sales: Products $ 5,273,710 $ 5,230,515 $ 5,136,859 Services and other 981,574 805,452 670,290 Total net sales 6,255,284 6,035,967 5,807,149 Cost of sales: Products 3,269,628 3,035,249 2,875,313 Services and other 631,821 573,611 505,226 Total cost of sales 3,901,449 3,608,860 3,380,539 Gross profit 2,353,835 2,427,107 2,426,610 Selling, general and administrative expenses 2,311,625 2,201,548 2,160,539 Goodwill impairment 1,222,524 — — Operating (loss) income (1,180,314 ) 225,559 266,071 Interest income (3,405 ) (1,032 ) (62 ) Interest expense 150,909 101,643 77,397 Loss on extinguishment and modification of debt 920 — 20,838 Other non-operating (income) loss (4,727 ) 12,667 (34,497 ) (Loss) income before income taxes and income from equity method investees (1,324,011 ) 112,281 202,395 Income tax (benefit) expense (27,613 ) 35,347 53,473 Income from equity method investees (16,188 ) (12,976 ) (10,883 ) Net (loss) income (1,280,210 ) 89,910 159,805 Net loss attributable to noncontrolling interest — (891 ) (4,612 ) Net (loss) income attributable to Class A and B-1 common stockholders $ (1,280,210 ) $ 90,801 $ 164,417 52 Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (53 weeks) (52 weeks) (52 weeks) Net sales: Products 84.3 % 86.7 % 88.5 % Services and other 15.7 13.3 11.5 Total net sales 100.0 100.0 100.0 Cost of sales: Products 52.3 50.3 49.5 Services and other 10.1 9.5 8.7 Total cost of sales 62.4 59.8 58.2 Gross profit 37.6 40.2 41.8 Selling, general and administrative expenses 37.0 36.5 37.2 Goodwill impairment 19.5 — — Operating (loss) income (18.9 ) 3.7 4.6 Interest income (0.1 ) (0.0 ) (0.0 ) Interest expense 2.5 1.6 1.3 Loss on extinguishment and modification of debt 0.0 — 0.4 Other non-operating (income) loss (0.1 ) 0.2 (0.6 ) (Loss) income before income taxes and income from equity method investees (21.2 ) 1.9 3.5 Income tax (benefit) expense (0.4 ) 0.6 0.9 Income from equity method investees (0.3 ) (0.2 ) (0.2 ) Net (loss) income (20.5 ) 1.5 2.8 Net loss attributable to noncontrolling interest — 0.0 0.0 Net (loss) income attributable to Class A and B-1 common stockholders (20.5 )% 1.5 % 2.8 % Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (53 weeks) (52 weeks) (52 weeks) Operational Data: Comparable sales increase 1.8 % 4.5 % 18.9 % Total pet care centers (U.S. and Puerto Rico) at end of period 1,423 1,430 1,433 Total veterinarian practices at end of period 288 247 197 Fiscal 2023 (53 weeks) Compared with Fiscal 2022 (52 weeks) Net Sales and Comparable Sales Fiscal years ended (dollars in thousands) February 3, 2024 January 28, 2023 $ Change % Change Consumables $ 3,063,845 $ 2,859,602 $ 204,243 7.1 % Supplies and companion animals 2,209,865 2,370,913 (161,048 ) (6.8 %) Services and other 981,574 805,452 176,122 21.9 % Net sales $ 6,255,284 $ 6,035,967 $ 219,317 3.6 % Net sales increased $219.3 million, or 3.6%, to $6.26 billion in fiscal 2023 compared to net sales of $6.04 billion in fiscal 2022, driven by a 1.8% increase in our comparable sales and an increase of $116.6 million as a result of the 53rd week in fiscal 2023.
Biggest changeResults of Operations The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands): Fiscal years ended February 1, 2025 February 3, 2024 January 28, 2023 (52 weeks) (53 weeks) (52 weeks) Net sales: Products $ 5,116,891 $ 5,273,710 $ 5,230,515 Services and other 999,571 981,574 805,452 Total net sales 6,116,462 6,255,284 6,035,967 Cost of sales: Products 3,173,269 3,269,628 3,035,249 Services and other 618,791 631,821 573,611 Total cost of sales 3,792,060 3,901,449 3,608,860 Gross profit 2,324,402 2,353,835 2,427,107 Selling, general and administrative expenses 2,317,351 2,311,625 2,201,548 Goodwill impairment — 1,222,524 — Operating income (loss) 7,051 (1,180,314 ) 225,559 Interest income (3,714 ) (3,405 ) (1,032 ) Interest expense 143,531 150,909 101,643 Loss on partial extinguishment of debt — 920 — Other non-operating (income) loss (4,800 ) (4,727 ) 12,667 (Loss) income before income taxes and income from equity method investees (127,966 ) (1,324,011 ) 112,281 Income tax (benefit) expense (7,481 ) (27,613 ) 35,347 Income from equity method investees (18,669 ) (16,188 ) (12,976 ) Net (loss) income (101,816 ) (1,280,210 ) 89,910 Net loss attributable to noncontrolling interest — — (891 ) Net (loss) income attributable to Class A and B-1 common stockholders $ (101,816 ) $ (1,280,210 ) $ 90,801 50 Fiscal years ended February 1, 2025 February 3, 2024 January 28, 2023 (52 weeks) (53 weeks) (52 weeks) Net sales: Products 83.7 % 84.3 % 86.7 % Services and other 16.3 15.7 13.3 Total net sales 100.0 100.0 100.0 Cost of sales: Products 51.9 52.3 50.3 Services and other 10.1 10.1 9.5 Total cost of sales 62.0 62.4 59.8 Gross profit 38.0 37.6 40.2 Selling, general and administrative expenses 37.9 37.0 36.5 Goodwill impairment — 19.5 — Operating income (loss) 0.1 (18.9 ) 3.7 Interest income (0.1 ) (0.1 ) (0.0 ) Interest expense 2.4 2.5 1.6 Loss on partial extinguishment of debt — 0.0 — Other non-operating (income) loss (0.1 ) (0.1 ) 0.2 (Loss) income before income taxes and income from equity method investees (2.1 ) (21.2 ) 1.9 Income tax (benefit) expense (0.1 ) (0.4 ) 0.6 Income from equity method investees (0.3 ) (0.3 ) (0.2 ) Net (loss) income (1.7 ) (20.5 ) 1.5 Net loss attributable to noncontrolling interest — — 0.0 Net (loss) income attributable to Class A and B-1 common stockholders (1.7 )% (20.5 )% 1.5 % Fiscal years ended February 1, 2025 February 3, 2024 January 28, 2023 (52 weeks) (53 weeks) (52 weeks) Operational Data: Comparable sales increase 0.3 % 1.8 % 4.5 % Total pet care centers (U.S. and Puerto Rico) at end of period 1,398 1,423 1,430 Adjusted EBITDA (in thousands) $ 336,526 $ 401,103 $ 530,769 Fiscal 2024 (52 weeks) Compared with Fiscal 2023 (53 weeks) Net Sales and Comparable Sales Fiscal years ended (dollars in thousands) February 1, 2025 February 3, 2024 $ Change % Change Consumables $ 3,043,178 $ 3,063,845 $ (20,667 ) (0.7 %) Supplies and companion animals 2,073,713 2,209,865 (136,152 ) (6.2 %) Services and other 999,571 981,574 17,997 1.8 % Net sales $ 6,116,462 $ 6,255,284 $ (138,822 ) (2.2 %) Net sales decreased $138.8 million, or 2.2%, to $6.12 billion in fiscal 2024 compared to net sales of $6.26 billion in fiscal 2023, primarily driven by $116.6 million attributable to the 53rd week in fiscal 2023.
Our cost of sales includes the following types of expenses: • direct costs (net of vendor rebates, allowances, and discounts for products sold) including inbound freight charges; • shipping and handling costs associated with sales to customers; • freight costs associated with moving merchandise inventories; • inventory shrinkage costs and write-downs; • payroll and benefit costs of pet groomers, trainers, veterinarians, and other direct costs of services; and 49 • costs associated with operating our distribution centers including payroll and benefits, occupancy costs, and depreciation.
Our cost of sales includes the following types of expenses: • direct costs (net of vendor rebates, allowances, and discounts for products sold) including inbound freight charges; • shipping and handling costs associated with sales to customers; • freight costs associated with moving merchandise inventories; • inventory shrinkage costs and write-downs; • payroll and benefit costs of pet groomers, trainers, veterinarians, and other direct costs of services; and • costs associated with operating our distribution centers including payroll and benefits, occupancy costs, and depreciation.
We perform our annual impairment test during the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Management has the option to first perform a qualitative assessment of its trade name asset to determine whether it is necessary to perform a quantitative impairment test.
We perform our annual impairment test during the fourth 59 quarter of each year or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Management has the option to first perform a qualitative assessment of its trade name asset to determine whether it is necessary to perform a quantitative impairment test.
Selling, General, and Administrative Expense The following types of expenses are included in our selling, general, and administrative costs (“SG&A”): • payroll and benefit costs of pet care center employees and corporate employees; • occupancy and operating costs of pet care centers and corporate facilities; • depreciation and amortization related to pet care centers and corporate assets; • credit card fees; • store pre-opening and remodeling costs; • advertising costs; and • other selling and administrative costs.
Selling, General, and Administrative Expense The following types of expenses are included in our selling, general, and administrative costs (“SG&A”): • payroll and benefit costs of pet care center employees and corporate employees; • occupancy and operating costs of pet care centers and corporate facilities; • depreciation and amortization related to pet care centers and corporate assets; • credit card fees; • store pre-opening and remodeling costs; • advertising costs; and 48 • other selling and administrative costs.
Macroeconomic factors, including rising interest rates, inflationary pressures, supply chain constraints, and global economic and geopolitical developments have had varying impacts on our results of operations, such as decreases in sales of discretionary items like supplies, that are difficult to isolate and quantify.
Macroeconomic factors, including rising interest rates, inflationary pressures, supply chain constraints, tariffs, and global economic and geopolitical developments have had varying impacts on our results of operations, such as decreases in sales of discretionary items like supplies, that are difficult to isolate and quantify.
Principal payments are typically $4.25 million quarterly. In March 2023, May 2023 and August 2023, the Company repaid $35.0 million, $25.0 million and $15.0 million in principal, respectively, of the First Lien Term Loan using existing cash on hand. The repayments were applied to remaining principal payments in order of scheduled payment date.
Principal payments are typically $4.25 million quarterly. The Company voluntarily repaid $35.0 million, $25.0 million and $15.0 million of the principal of the First Lien Term Loan using existing cash on hand in March 2023, May 2023, and August 2023, respectively. The repayments were applied to remaining principal payments in order of scheduled payment date.
A new location or digital site is included in comparable sales beginning on the first day of the fiscal month following 12 full fiscal months of operation and is subsequently compared to like time periods from the previous year.
A new location or digital site is included in comparable sales beginning on the first 46 day of the fiscal month following 12 full fiscal months of operation and is subsequently compared to like time periods from the previous year.
How We Assess the Performance of Our Business In assessing our performance, we consider a variety of performance and financial measures including the following: 47 Comparable Sales Comparable sales is an important measure throughout the retail industry and includes both retail and digital sales of products and services.
How We Assess the Performance of Our Business In assessing our performance, we consider a variety of performance and financial measures including the following: Comparable Sales Comparable sales is an important measure throughout the retail industry and includes both retail and digital sales of products and services.
The discussion and analysis below contain certain forward-looking statements about our business and operations that are subject to the risks, uncertainties, and other factors described in the section entitled “Risk Factors,” included in Part I, Item 1A, and elsewhere in this Annual Report on Form 10-K.
The discussion and analysis below contains certain forward-looking statements about our business and operations that are subject to the risks, uncertainties, and other factors described in the section entitled “Risk Factors,” included in Part I, Item 1A, and elsewhere in this Annual Report on Form 10-K.
We are increasingly linking our offerings with membership programs such as Vital Care Premier and pet health insurance in an effort to create deeper engagement with our customers, and with our Vital Care Core loyalty program members specifically, which members accounted for over 90% of transactions in fiscal 2023.
We are increasingly linking our offerings with membership programs such as Vital Care Premier and pet health insurance in an effort to create deeper engagement with our customers, and with our Vital Care Core loyalty program members specifically, which members accounted for over 90% of transactions in fiscal 2024.
Management believes that Free Cash Flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance. 56 Although other companies report their free cash flow, numerous methods exist for calculating a company’s free cash flow.
Management believes that Free Cash Flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance. 54 Although other companies report their free cash flow, numerous methods exist for calculating a company’s free cash flow.
Refer also to further discussion on our debt refinancing transaction in “Sources of Liquidity” below. Purchase obligations and commitments consist of open purchase orders, non-cancellable commitments for information technology, marketing and other products and services used in the normal course of business as well as our commitment for naming rights to the baseball stadium.
Refer also to further discussion on our debt refinancing transaction in “Sources of Liquidity” below. Purchase obligations and commitments consist of open purchase orders, as well as non-cancellable commitments for information technology, marketing and other products and services used in the normal course of business. We also have a commitment for naming rights to the baseball stadium.
In December 2022, we amended our first lien term loan facility and our revolving credit facility to replace the LIBOR-based rate with a SOFR-based rate as the interest rate benchmark. Please read the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
In December 2022, we amended our first lien term loan facility and our revolving credit facility to replace the LIBOR-based rate with a SOFR-based rate as the interest rate benchmark. Refer to the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
However, if estimates of losses are inaccurate, we may be exposed to losses or gains that could be material. A 10% difference in our actual shrink reserve at February 3, 2024 would have affected pre-tax loss by $3.5 million in fiscal 2023. Vendor Allowances We receive various forms of consideration from our merchandise vendors (vendor allowances).
However, if estimates of losses are inaccurate, we may be exposed to losses or gains that could be material. A 10% difference in our actual shrink reserve at February 1, 2025 would have affected pre-tax loss by $3.3 million in fiscal 2024. Vendor Allowances We receive various forms of consideration from our merchandise vendors (vendor allowances).
Refer to Note 5, “ Leases ,” and Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for amounts outstanding as of February 3, 2024 related to operating leases and debt, respectively.
Refer to Note 5, “ Leases ,” and Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for amounts outstanding as of February 1, 2025 related to operating leases and debt, respectively.
These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the consolidated balance sheet as of February 3, 2024, while others are considered future obligations. Our contractual obligations primarily consist of operating leases and long-term debt and related interest payments.
These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the consolidated balance sheet as of February 1, 2025, while others are considered future obligations. Our contractual obligations primarily consist of operating leases and long-term debt and related interest payments.
Historically, adjustments to our vendor income deferral have not been material. A 10% difference in our vendor income deferred at February 3, 2024 would have affected pre-tax loss by $2.3 million in fiscal 2023. We have not made any material changes in the accounting methodology we use to assess vendor allowances during the past three fiscal years.
Historically, adjustments to our vendor income deferral have not been material. A 10% difference in our vendor income deferred at February 1, 2025 would have affected pre-tax loss by $2.2 million in fiscal 2024. 58 We have not made any material changes in the accounting methodology we use to assess vendor allowances during the past three fiscal years.
In response to this shifting demand, during fiscal 2023, we broadened our assortment to include more national brands and implemented strategic pricing actions to offer more balanced price points in an effort to appeal to a broader base of consumers.
In response to this shifting demand, we have broadened our assortment to include more national brands and implemented strategic pricing actions to offer more balanced price points in an effort to appeal to a broader base of consumers.
Please read the discussion of these assets under “Critical Accounting Policies and Estimates.” Interest Expense Our interest expense in fiscal 2021 was primarily associated with a term loan facility, and a revolving credit facility.
Please read the discussion of these assets under “Critical Accounting Policies and Estimates.” Interest Expense Our interest expense in fiscal 2022 was primarily associated with a first lien term loan facility and a revolving credit facility.
We are unable to quantify the factors impacting gross profit rate described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification. Selling, General and Administrative Expenses SG&A expenses increased $110.1 million, or 5.0%, to $2.31 billion for fiscal 2023 compared to $2.20 billion for fiscal 2022.
We are unable to quantify the factors impacting gross profit rate described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification. Selling, General and Administrative Expenses SG&A expenses increased $5.7 million, or 0.2%, to $2.32 billion for fiscal 2024 compared to $2.31 billion for fiscal 2023.
Through our omnichannel ecosystem, we provide our customers with a comprehensive offering of products and services to fulfill their pets’ health and wellness needs through our more than 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, including a growing network of 288 full service veterinary hospitals, our digital channel, and our flexible fulfillment options.
Through our omnichannel ecosystem, we provide our customers with a comprehensive offering of products and services to fulfill their pets’ needs through our more than 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, including a network of in-store veterinary hospitals, our digital channel, and our flexible fulfillment options.
As a percentage of net sales, SG&A expenses increased from 36.5% in fiscal 2022 to 37.0% in fiscal 2023. The increase in SG&A expenses period-over-period was to support our growth as we continue to invest in infrastructure and our people.
As a percentage of net sales, SG&A expenses increased from 37.0% in fiscal 2023 to 37.9% in fiscal 2024. The increase in SG&A expenses period-over-period was to support our growth as we continue to invest in infrastructure and our people.
Net Income (Loss) Attributable to Class A and B-1 Common Stockholders Net loss attributable to Class A and B-1 common stockholders was $(1,280.2) million for fiscal 2023 compared with a net income attributable to Class A and B-1 common stockholders of $90.8 million for fiscal 2022.
Net (Loss) Income Attributable to Class A and B-1 Common Stockholders Net loss attributable to Class A and B-1 common stockholders was $101.8 million for fiscal 2024 compared with a net loss attributable to Class A and B-1 common stockholders of $1,280.2 million for fiscal 2023.
The decrease in effective tax rate in fiscal 2023 as compared to fiscal 2022 is primarily driven by non-deductible goodwill impaired during the third quarter of fiscal 2023, in addition to a shortfall in tax deductions resulting from the exercise and vesting of equity-based compensation awards.
The increase in effective tax rate in fiscal 2024 as compared to fiscal 2023 is primarily driven by non-deductible goodwill impaired during fiscal 2023, in addition to a shortfall in tax deductions resulting from the exercise and vesting of equity-based compensation awards.
Prior Year Discussion of Results and Comparisons For information on fiscal 2022 results and similar comparisons, please read “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our previous Annual Report on Form 10-K filed with the SEC on March 28, 2023.
Prior Year Discussion of Results and Comparisons For information on fiscal 2023 results and similar comparisons, please read “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our previous Annual Report on Form 10-K filed with the SEC on April 3, 2024.
Sources of Liquidity Senior Secured Credit Facilities On March 4, 2021, the Company completed a refinancing transaction by entering into a $1,700 million secured term loan facility maturing on March 4, 2028 (the “First Lien Term Loan”) and the ABL Revolving Credit Facility, which matures on March 4, 2026 and has availability of up to $500.0 million, subject to a borrowing base.
Sources of Liquidity Senior Secured Credit Facilities On March 4, 2021, the Company completed a refinancing transaction by entering into the $1,700.0 million First Lien Term Loan maturing on March 4, 2028 and the ABL Revolving Credit Facility, originally maturing on March 4, 2026 with availability of up to $500.0 million, subject to a borrowing base.
Goodwill Impairment In fiscal 2023, the Company recorded a pre-tax goodwill impairment charge of $1.22 billion as a result of performing an interim impairment test in the third quarter of fiscal 2023 due to the identification of certain triggering events.
Goodwill Impairment In fiscal 2023, the Company recorded a pre-tax goodwill impairment charge of $1.22 billion as a result of performing an interim impairment test due to the identification of certain triggering events. There was no goodwill impairment charge recorded in fiscal 2024.
(“Petco”, the “Company”, “we”, “our” and “us”) is a pet health and wellness company focused on improving the lives of pets, pet parents, and our own partners.
(“Petco”, the “Company”, “we”, “our” and “us”) is a pet specialty retailer focused on improving the lives of pets, pet parents, and our own partners.
All other key terms of the ABL Revolving Credit Facility remained unchanged. For more information regarding this indebtedness, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information regarding this indebtedness, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Cash Flows The following table summarizes our consolidated cash flows: Fiscal years ended (dollars in thousands) February 3, 2024 January 28, 2023 January 29, 2022 (52 weeks) (52 weeks) (52 weeks) Total cash provided by (used in): Operating activities $ 215,719 $ 346,003 $ 358,215 Investing activities (207,445 ) (320,324 ) (237,083 ) Financing activities (85,352 ) (33,842 ) (18,782 ) Net (decrease) increase in cash, cash equivalents and restricted cash $ (77,078 ) $ (8,163 ) $ 102,350 57 Operating Activities Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity.
Cash Flows The following table summarizes our consolidated cash flows: Fiscal years ended (dollars in thousands) February 1, 2025 February 3, 2024 January 28, 2023 (52 weeks) (53 weeks) (52 weeks) Total cash provided by (used in): Operating activities $ 177,673 $ 215,719 $ 346,003 Investing activities (123,903 ) (207,445 ) (320,324 ) Financing activities (8,754 ) (85,352 ) (33,842 ) Net increase (decrease) in cash, cash equivalents and restricted cash $ 45,016 $ (77,078 ) $ (8,163 ) 55 Operating Activities Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity.
However, during fiscal 2023, we observed a softening in discretionary spend and shifting consumer preferences for more value-centric products associated with the current inflationary macroeconomic environment.
However, during fiscal 2024, we continued to observe a softening discretionary spend and shifting consumer preferences for more value-centric products associated with the current inflationary macroeconomic environment.
A 10% difference in our actual valuation reserve at February 3, 2024 would have affected pre-tax loss by $1.6 million in fiscal 2023. Additionally, we do not believe there is a reasonable likelihood that there will be a material change in future estimates or assumptions we use to calculate our shrink 60 reserve.
A 10% difference in our actual valuation reserve at February 1, 2025 would have an insignificant effect on pre-tax loss in fiscal 2024. Additionally, we do not believe there is a reasonable likelihood that there will be a material change in future estimates or assumptions we use to calculate our shrink reserve.
For more information on this charge, refer to Note 6, "Goodwill," to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this of this Annual Report on Form 10-K. Interest Expense Interest expense increased $49.3 million, or 48.5%, to $150.9 million in fiscal 2023 compared with $101.6 million in fiscal 2022.
For more information refer to Note 6, "Goodwill," to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this of this Annual Report on Form 10-K. Interest Expense Interest expense decreased $7.4 million, or 4.9%, to $143.5 million in fiscal 2024 compared with $150.9 million in fiscal 2023.
In addition, other companies in our industry may define Adjusted EBITDA differently, limiting its usefulness as a comparative measure. 55 The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (dollars in thousands) (53 weeks) (52 weeks) (52 weeks) Net (loss) income attributable to Class A and B-1 common stockholders $ (1,280,210 ) $ 90,801 $ 164,417 Interest expense, net 147,504 100,611 77,335 Income tax (benefit) expense (27,613 ) 35,347 53,473 Depreciation and amortization 200,782 193,828 172,431 Income from equity method investees (16,188 ) (12,976 ) (10,883 ) Loss on extinguishment and modification of debt 920 — 20,838 Goodwill impairment 1,222,524 — — Asset impairments and write offs 2,833 1,992 10,918 Equity-based compensation expense 81,859 60,784 49,265 Other non-operating (income) loss (4,727 ) 12,667 (34,497 ) Mexico joint venture EBITDA (1) 38,226 29,584 26,837 Acquisition-related integration costs (2) — 15,314 — Other costs (3) 35,193 2,817 18,235 Adjusted EBITDA $ 401,103 $ 530,769 $ 548,369 Net sales $ 6,255,284 $ 6,035,967 $ 5,807,149 Net margin (4) (20.5 )% 1.5 % 2.8 % Adjusted EBITDA Margin 6.4 % 8.8 % 9.4 % (1) Mexico joint venture EBITDA represents 50% of the entity’s operating results for the periods presented, as adjusted to reflect the results on a basis comparable to our Adjusted EBITDA.
In addition, other companies in our industry may define Adjusted EBITDA differently, limiting its usefulness as a comparative measure. 53 The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Fiscal years ended February 1, 2025 February 3, 2024 January 28, 2023 (dollars in thousands) (52 weeks) (53 weeks) (52 weeks) Net (loss) income attributable to Class A and B-1 common stockholders $ (101,816 ) $ (1,280,210 ) $ 90,801 Interest expense, net 139,817 147,504 100,611 Income tax (benefit) expense (7,481 ) (27,613 ) 35,347 Depreciation and amortization 199,727 200,782 193,828 Income from equity method investees (18,669 ) (16,188 ) (12,976 ) Loss on partial extinguishment of debt — 920 — Goodwill impairment — 1,222,524 — Asset impairments and write offs 8,790 2,833 1,992 Equity-based compensation expense 50,212 81,859 60,784 Other non-operating (income) loss (4,800 ) (4,727 ) 12,667 Mexico joint venture EBITDA (1) 41,615 38,226 29,584 Acquisition and divestiture-related integration costs (2) 3,719 — 15,314 Other costs (3) 25,412 35,193 2,817 Adjusted EBITDA $ 336,526 $ 401,103 $ 530,769 Net sales $ 6,116,462 $ 6,255,284 $ 6,035,967 Net margin (4) (1.7 )% (20.5 )% 1.5 % Adjusted EBITDA Margin 5.5 % 6.4 % 8.8 % (1) Mexico joint venture EBITDA represents 50% of the entity’s operating results for the periods presented, as adjusted to reflect the results on a basis comparable to our Adjusted EBITDA.
The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA: Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (dollars in thousands) (53 weeks) (52 weeks) (52 weeks) Net income $ 32,375 $ 24,757 $ 21,773 Depreciation 26,141 19,820 15,679 Income tax expense 11,449 9,409 11,390 Foreign currency loss (gain) 1,520 (268 ) (431 ) Interest expense, net 4,966 5,449 5,263 EBITDA $ 76,451 $ 59,167 $ 53,674 50% of EBITDA $ 38,226 $ 29,584 $ 26,837 (2) Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses.
The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA: Fiscal years ended February 1, 2025 February 3, 2024 January 28, 2023 (dollars in thousands) (52 weeks) (53 weeks) (52 weeks) Net income $ 37,559 $ 32,375 $ 24,757 Depreciation 27,360 26,141 19,820 Income tax expense 16,010 11,449 9,409 Foreign currency loss (gain) 169 1,520 (268 ) Interest expense, net 2,131 4,966 5,449 EBITDA $ 83,229 $ 76,451 $ 59,167 50% of EBITDA $ 41,615 $ 38,226 $ 29,584 (2) Acquisition and divestiture-related integration costs include direct costs resulting from acquiring, integrating, or divesting businesses.
If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that a reporting unit’s fair value is greater than its carrying value, no further impairment testing is required. 61 If management’s assessment of qualitative factors indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then a quantitative assessment is performed.
If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that a reporting unit’s fair value is greater than its carrying value, no further impairment testing is required.
Net Loss Attributable to Noncontrolling Interest The noncontrolling interest represents 50% of the net loss of our veterinary joint venture, which was a variable interest entity for which we were deemed to be the primary beneficiary beginning in fiscal 2019 due to revisions made in the joint operating agreement.
Net Loss Attributable to Noncontrolling Interest The noncontrolling interest represents 50% of the net loss of our veterinary joint venture, which was a variable interest entity for which we were deemed to be the primary beneficiary.
For more information refer to Note 9, “Fair Value Measurements,” to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
The table below reflects the calculation of Free Cash Flow for the periods presented: Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (dollars in thousands) (53 weeks) (52 weeks) (52 weeks) Net cash provided by operating activities $ 215,719 $ 346,003 $ 358,215 Cash paid for fixed assets (225,598 ) (278,020 ) (239,110 ) Free Cash Flow $ (9,879 ) $ 67,983 $ 119,105 Liquidity and Capital Resources Overview Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”).
The table below reflects the calculation of Free Cash Flow for the periods presented: Fiscal years ended February 1, 2025 February 3, 2024 January 28, 2023 (dollars in thousands) (52 weeks) (53 weeks) (52 weeks) Net cash provided by operating activities $ 177,673 $ 215,719 $ 346,003 Cash paid for fixed assets (127,990 ) (225,598 ) (278,020 ) Free Cash Flow $ 49,683 $ (9,879 ) $ 67,983 Liquidity and Capital Resources Overview Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our $581 million ABL Revolving Credit Facility.
In June 2023, the Company entered into an interest rate collar agreement to limit the maximum interest on a portion of the Company’s variable-rate debt and decrease its exposure to interest rate variability relating to three-month Term SOFR.
Derivative Instruments The Company entered into interest rate cap, collar and swap agreements to limit the maximum interest on a portion of the Company’s variable-rate debt and decrease its exposure to interest rate variability relating to three-month Term SOFR.
Gross Profit Gross profit decreased $73.3 million, or 3.0%, to $2.35 billion in fiscal 2023 compared to gross profit of $2.43 billion for fiscal 2022. As a percentage of sales, our gross profit rate was 37.6% for fiscal 2023 compared to 40.2% for fiscal 2022.
Gross Profit Gross profit decreased $29.4 million, or 1.3%, to $2.32 billion in fiscal 2024 compared to gross profit of $2.35 billion for fiscal 2023. As a percentage of sales, our gross profit rate was 38.0% for fiscal 2024 compared to 37.6% for fiscal 2023.
This is the primary focus of our customer engagement efforts from digital, to performance marketing campaigns, to new product introductions, and to Petco partner cross- and up-selling activities in pet care centers.
This is the primary focus of our customer engagement efforts from digital, to performance marketing campaigns, to new product introductions, and to Petco partner cross- and up-selling activities in pet care centers. The ability to convert more of our customers to loyal, multi-channel shoppers will positively affect business performance.
Financing cash flows in fiscal 2022 primarily consisted of borrowings and repayments under the ABL Revolving Credit Facility, quarterly term loan repayments, and payments for tax withholdings on stock-based awards. Financing cash flows in fiscal 2021 primarily consisted of borrowings and repayments of debt in connection with the March 4, 2021 debt refinancing transaction discussed under “Sources of Liquidity” below.
Financing cash flows in fiscal 2022 primarily consisted of borrowings and repayments under the ABL Revolving Credit Facility, quarterly term loan repayments, and payments for tax withholdings on stock-based awards.
Critical Accounting Policies and Estimates The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make assumptions and estimates about future results and apply judgments that affect the reported amounts of assets, liabilities, net sales, expenses and related disclosures.
Seasonality Our financial performance is not significantly impacted by seasonality, as the majority of our sales are generated by pet parents caring for their pets year-round. 57 Critical Accounting Policies and Estimates The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make assumptions and estimates about future results and apply judgments that affect the reported amounts of assets, liabilities, net sales, expenses and related disclosures.
Our interest expense in fiscal 2022 was primarily associated with a first lien term loan facility and a revolving credit facility. In November 2022, we entered into a series of interest rate cap agreements to limit the maximum interest on a portion of our variable-rate debt and decrease our exposure to interest rate variability.
In November 2022, we entered into a series of interest rate cap agreements to limit the maximum interest on a portion of our variable-rate debt and decrease our exposure to interest rate variability.
As of February 3, 2024, our purchase obligations and commitments were $349.0 million of which $281.1 million is considered short-term.
As of February 1, 2025, our purchase obligations and commitments were $321.1 million of which $270.5 million is considered short-term.
The decrease in capital expenditures between fiscal 2023 and fiscal 2022 was primarily driven by reductions in capital spend partially offset by proceeds received from the sale of our investment in Rover Group, Inc. Additionally, in fiscal 2022, we paid $35.0 million for the remaining 50% stake in our veterinary joint venture.
In fiscal 2025, we expect to spend approximately $130 million to $140 million in capital expenditures. The decrease in capital expenditures between fiscal 2023 and fiscal 2022 was primarily driven by reductions in capital spend partially offset by proceeds received from the sale of our investment in Rover Group, Inc.
Our liquidity as of February 3, 2024 was $572.0 million inclusive of cash and cash equivalents of $125.4 million and $446.6 million of availability on the ABL Revolving Credit Facility.
Our liquidity as of February 1, 2025 was $681.4 million inclusive of cash and cash equivalents of $165.8 million and $515.6 million of availability on the ABL Revolving Credit Facility.
The second tranche has availability of up to $546.0 million, subject to a borrowing base, maturing on March 29, 2029. Interest on the ABL Revolving Credit Facility is now based on, at the Company's option, either the base rate subject to a 1% floor, or Term SOFR subject to a floor of 0%, plus an applicable margin.
Interest on the ABL Revolving Credit Facility is now based on, at the Company's option, either the base rate subject to a 1% floor, or Term SOFR subject to a floor of 0%, plus an applicable margin. All other key terms of the ABL Revolving Credit Facility remained unchanged.
In March 2024, the Company amended the ABL Revolving Credit Facility, which now consists of two tranches, to increase its total availability from $500.0 million to $581.0 million and extend the maturity on a portion of this availability. The first tranche has availability of up to $35.0 million, subject to a borrowing base, maturing on March 4, 2026.
The next scheduled principal payment is expected to occur in fiscal 2027. In March 2024, the Company amended the ABL Revolving Credit Facility, which now consists of two tranches, to increase its total availability from $500.0 million to $581.0 million and extend the maturity on a portion of this availability.
Capital expenditures by category during the periods set forth below are as follows: Fiscal years ended (dollars in thousands) February 3, 2024 January 28, 2023 January 29, 2022 New and existing pet care center locations $ 121,815 $ 146,432 $ 140,721 Digital and information technology 70,598 78,611 57,319 Supply chain and other 33,185 52,977 41,070 Total capital expenditures $ 225,598 $ 278,020 $ 239,110 Financing Activities Net cash used in financing activities was $85.4 million for fiscal 2023, compared with $33.8 million used in financing activities in fiscal 2022 and $18.8 million used in financing activities in fiscal 2021. 58 Financing cash flows in fiscal 2023 primarily consisted of $75.0 million in principal repayments on the term loan, borrowings and repayments under the ABL Revolving Credit Facility, and payments for tax withholdings on stock-based awards.
Capital expenditures by category during the periods set forth below are as follows: Fiscal years ended (dollars in thousands) February 1, 2025 February 3, 2024 January 28, 2023 New and existing pet care center locations $ 46,084 $ 121,815 $ 146,432 Digital and information technology 51,948 70,598 78,611 Supply chain and other 29,958 33,185 52,977 Total capital expenditures $ 127,990 $ 225,598 $ 278,020 Financing Activities Net cash used in financing activities was $8.8 million for fiscal 2024, compared with $85.4 million used in financing activities in fiscal 2023 and $33.8 million used in financing activities in fiscal 2022.
A 10% change in our self-insurance reserves at February 3, 2024 would have affected pre-tax loss by $8.9 million in fiscal 2023. 62 Recent Accounting Pronouncements Refer to Note 1, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.
Recent Accounting Pronouncements Refer to Note 1, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.
Investing Activities Net cash used in investing activities was $207.4 million, $320.3 million, and $237.1 million for fiscal 2023, fiscal 2022, and fiscal 2021, respectively, and consisted primarily of capital expenditures supporting our growth and initiatives.
Investing Activities Net cash used in investing activities was $123.9 million, $207.4 million, and $320.3 million for fiscal 2024, fiscal 2023, and fiscal 2022, respectively, and consisted primarily of capital expenditures supporting our growth and initiatives. The decrease in capital expenditures between fiscal 2024 and fiscal 2023 was primarily driven by reductions in new pet care centers and hospitals.
Income Tax Expense (Benefit) Income taxes consist of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for allowable credits, deductions, and the valuation allowance against deferred tax assets, as applicable. 50 Income from Equity Method Investees Investments for which the Company exercises significant influence but does not have control are accounted for under the equity method.
Income Tax (Benefit) Expense Income taxes consist of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for allowable credits, deductions, and the valuation allowance against deferred tax assets, as applicable.
For more information regarding these activities, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. 54 Other Non-Operating (Income) Loss Other non-operating income was $4.7 million and other non-operating loss was $12.7 million for fiscal 2023 and fiscal 2022, respectively.
For more information refer to Note 7, “ Senior Secured Credit Facilities ,” and Note 8, "Derivative Instruments," in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. Loss on Extinguishment and Modification of Debt In fiscal 2023, the Company recognized $0.9 million of losses on partial extinguishment of debt.
The decrease in operating cash flow was due to lower operating income, higher interest payments, higher cash paid for payroll and fringe as well as payouts of prior year accrued incentive bonuses. This was partially offset by lower cash paid for advertising and lower cash payments on operating leases due to the timing of rent payments.
The decrease in operating cash flow was driven by an increase in inventory purchases, higher payroll and fringe benefits as well as increases in cash paid for interest and operating leases. This was partially offset by an increase in sales, effective management of accounts payable, and lower payouts of prior year accrued incentive bonuses.
These investments include: expansion of our veterinary footprint, digital and e-commerce integration and expansion; enhanced supply chain capacity including additional distribution centers; data analytical capabilities; and marketing and advertising.
These investments have included: expansion of our veterinary footprint, digital and e-commerce integration and expansion; enhanced supply chain capacity including additional distribution centers; data analytical capabilities; and marketing and advertising. 47 Gross Margin and Expense Management Our operating results are impacted by our ability to convert revenue into healthy gross margin and operating margin.
Vital Care Premier memberships are at the top of our loyalty programs, followed by Vital Care Core and our perks programs that provide rewards for frequent purchasing. We strive to be a company that is improving millions of pet lives as well as the lives of pet parents and the partners who work for us.
We strive to be a company that is improving millions of pet lives as well as the lives of pet parents and the partners who work for us.
Our multicategory strategy integrates our digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pet’s needs.
Our multicategory strategy integrates our digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pets' needs. Our e-commerce site and mobile app serve as hubs for pet parents to manage their pets’ needs, while enabling them to shop wherever, whenever, and however they want.
(3) Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.
These include third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs that would not have otherwise been incurred as part of the Company’s operations. (3) Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.
Equity method investment activity is primarily related to a 50% joint venture with Grupo Gigante, S.A.B. de C.V. (the “Mexico joint venture”) to establish Petco locations in Mexico. The Company’s share of the investee’s results is presented as either income or loss from equity method investees in the accompanying consolidated statements of operations.
Income from Equity Method Investees Investments for which the Company exercises significant influence but does not have control are accounted for under the equity method. Equity method investment activity is primarily related to a 50% joint venture with Grupo Gigante, S.A.B. de C.V. (the “Mexico joint venture”) to establish Petco locations in Mexico.
Loss on Extinguishment and Modification of Debt In fiscal 2023, the Company recognized $0.9 million of losses on partial extinguishment of debt. This loss was recognized in conjunction with the $35.0 million, $25.0 million and $15.0 million repayments on the First Lien Term Loan in March 2023, May 2023 and August 2023, respectively.
This loss was recognized in conjunction with voluntary principal repayments on the First Lien Term Loan during fiscal 2023. The Company did not recognize any losses on extinguishment or modification of debt in fiscal 2024.
Net cash provided by operating activities was $215.7 million in fiscal 2023 compared with net cash provided by operating activities of $346.0 million in fiscal 2022. The decrease in operating cash flow was driven by an increase in cash paid for inventory, higher payroll and fringe benefits as well as increases in cash paid for interest and operating leases.
This was partially offset by decreases in inventory purchases, advertising, freight, and cash paid for operating leases. Net cash provided by operating activities was $215.7 million in fiscal 2023 compared with $346.0 million in fiscal 2022.
We evaluate these assets for impairment annually and whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
Goodwill and Indefinite-Lived Intangible Impairment In connection with the fiscal 2015 acquisition by our Sponsors, we recorded goodwill of approximately $3.0 billion and an indefinite-lived trade name asset of $1.1 billion. We evaluate these assets for impairment annually and whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
The interest rate collars become effective on December 31, 2024 and expire on December 31, 2026. For more information regarding derivative instruments, refer to Note 8, “ Derivative Instruments ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information regarding derivative instruments, refer to Note 8, “ Derivative Instruments ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. Segment We operate under one reportable segment and support and serve pets and their parents through our integrated ecosystem of pet care centers, services, and e-commerce.
Service-related sales, which include veterinary hospitals, increased 15.3%, reflecting expansion and maturity of our veterinary hospital footprint and growth in our veterinary and grooming business. We are unable to quantify certain factors impacting sales described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification.
This was offset by a decrease in supplies and companion animals sales, driven by softening in discretionary spend. 51 We are unable to quantify certain factors impacting sales described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification.
The ability to convert more of our customers to loyal, multi-channel shoppers will positively affect business performance. 48 Innovation and Transformation We have made significant investments to support our innovation and business transformation strategies.
Innovation and Transformation We have made significant investments to support our innovation and business transformation strategies.
The decline period-over-period was primarily driven by a goodwill impairment charge of $1,222.5 million, higher SG&A costs of $110.1 million, higher interest expense of $49.3 million, offset partially by a $17.4 million change in the remeasurement of our investment in Rover Group, Inc.
The change period-over-period was primarily driven by a goodwill impairment charge of $1,222.5 million in fiscal 2023.
On March 4, 2021, we borrowed $1,700.0 million under a new first lien term loan facility, repaid all outstanding principal and interest on the existing term loan facility, and replaced our existing revolving credit facility with a new revolving credit facility. Please read the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
Refer to the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information. Our interest expense in fiscal 2024 was primarily associated with a first lien term loan facility, a revolving credit facility, an interest rate swap, and interest rate caps and collars.
The increase was primarily driven by higher interest rates on the First Lien Term Loan. For more information refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information refer to Note 9, “Fair Value Measurements,” to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. 52 Income Tax (Benefit) Expense Our effective tax rate was 6.8% for fiscal 2024, resulting in income tax benefit of $7.5 million, compared to an effective tax rate of 2.1% and income tax benefit of $27.6 million for fiscal 2023.
Refer to the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
During fiscal 2024, we entered into an interest rate collar agreement and an interest rate swap agreement to limit the maximum interest and to fix the interest on a portion of our variable-rate debt and decrease our exposure to interest rate variability. Refer to the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
We focus gross margin and expense management on achieving a balance between ensuring adequate resource spend to grow sales with attention to driving increased profitability. The business has successfully implemented cost optimization initiatives in the past and will continue to find opportunities to enhance profit margins and operate more efficiently in the future.
Along with managing gross margin, the other lever in delivering operating margin is expense management. The Company has implemented cost optimization initiatives in the past and expects to continue to find opportunities to operate more efficiently in the future. Talent and Culture We see our Petco partners as the core to building a purpose-driven performance culture.